Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | 0.0074 | 0.9 |
mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | 0.0048 | 0.9 |
mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.0047 | 0.9 |
mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.0075 | 0.9 |
mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.9 |
mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.0072 | 0.9 |
mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.0045 | 0.9 |
mRNA | Methotrexate | FIMM | pan-cancer | AAC | -0.018 | 0.9 |
mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.0041 | 0.9 |
mRNA | ML311 | CTRPv2 | pan-cancer | AAC | -0.0042 | 0.9 |